Tucaresol: A Unique Oral Candidate Drug Ideally Accessible for Treatment of Covid-19 Disease

Author:

Penney Christopher L.,Zacharie Boulos,Duceppe Jean-Simon

Publisher

SvedbergOpen

Reference40 articles.

1. Dunleavy, K. (2022). Pfizer Reveals Plan to Make its Products Available to 45 Poor Countries at Not-for-Profit Cost. FIERCE Pharma, May 25, 2022.

2. Becker, Z.,Dunleavy, K., Kansteiner, F. and Liu, A. (2022). COVID-19 Tracker. FIERCE Pharma, August 12, 2022.

3. Bendix, A. (2022). As More People Report Covid Rebounds After Paxlovid, Experts Insist Cases are Rare. NBC News, July 27, 2022.

4. Lipid Tucaresol as an Adjuvant for Methamphetamine Vaccine Development;Collins;Chem Commun (Camb) April 21,2014

5. Post-Treatment Control of HIV Infection;Conway;Proc Natl Acad Sci U S A April 13 2015,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3